Liposomes: Applications in Medicine
Open Access
- 1 July 2001
- journal article
- research article
- Published by SAGE Publications in Journal of Biomaterials Applications
- Vol. 16 (1), 3-21
- https://doi.org/10.1106/ra7u-1v9c-rv7c-8qxl
Abstract
Liposomes are spherical lipid bilayers from 50 nm to 1000 nm in diameter that serve as convenient delivery vehicles for biologically active compounds. The field of liposome research has expanded considerably over the last 30 years. It is now possible to engineer a wide range of liposomes varying in size, phospholipid composition and surface characteristics to suit the specific application for which they are intended. This paper gives an overview of the main advances in liposome research from a point of view of their applications in medicine. Aqueous contrast enhancing agents entrapped in liposomal carriers can be targeted to the liver and spleen and distinctions can be made between normal and tumorous tissue using computed tomography. Topical application of liposomes has great potential in dermatology. Liposomes have been used to deliver anticancer agents in order to reduce the toxic effects of the drugs when given alone or to increase the circulation time and effectiveness of the drugs. From the original concept of encapsulating hemoglobin in an inert shell, liposome-encapsulated hemoglobin (LEH) has evolved into a fluid proven to carry oxygen, capable of surviving for reasonable periods in the circulation and amenable to large-scale production. Liposomes may be used to target specific cells by attaching amino acid fragments such as antibodies or proteins or appropriate fragments that target specific receptor sites. Liposomal DNA delivery vectors and further enhancements in the forms of LPDI and LPDII are some of the safest and potentially most versatile transfer vectors used to date. DNA vaccination and improved efficiency of gene therapy are just a few of the upcoming applications of liposomes.Keywords
This publication has 70 references indexed in Scilit:
- Doxorubicin Encapsulated in Liposomes Containing Surface‐Bound Polyethylene Glycol: Pharmacokinetics, Tumor Localization, and Safety in Patients with AIDS‐Related Kaposi's SarcomaThe Journal of Clinical Pharmacology, 1996
- Sunscreens and T4N5 Liposomes Differ in Their Ability to Protect Against Ultraviolet-Induced Sunburn Cell Formation, Alterations of Dendritic Epidermal Cells, and Local Suppression of Contact HypersensitivityJournal of Investigative Dermatology, 1995
- New structures in complex formation between DNA and cationic liposomes visualized by freeze—fracture electron microscopyFEBS Letters, 1994
- Influence of the steric barrier activity of amphipathic poly(ethyleneglycol) and ganglioside GM1 on the circulation time of liposomes and on the target binding of immunoliposomes in vivoFEBS Letters, 1991
- Biodistribution and Clearance of Contrast-Carrying MREV LiposomesInvestigative Radiology, 1990
- Size Discrimination in Computed Tomographic Images Effects of Feature Contrast and Display WindowInvestigative Radiology, 1988
- Stability of liposomes invivo and invitro is promoted by their cholesterol content and the presence of blood cellsBiochemical and Biophysical Research Communications, 1979
- Protein-liposome interactions and their relevance to the structure and function of cell membranesMolecular and Cellular Biochemistry, 1976
- The effect of particle size and charge on the clearance rates of liposomes and liposome encapsulated drugsBiochemical and Biophysical Research Communications, 1975
- The diffusion of ions from a phospholipid model membrane systemProtoplasma, 1967